id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2012-N-0902-0001,FDA,FDA-2012-N-0902,New Animal Drugs: Chorionic Gonadotropin; Naloxone; Oxymorphone; Oxytocin,Rule,Final Rule,2012-09-10T04:00:00Z,2012,9,2012-09-10T04:00:00Z,,2012-09-10T15:20:51Z,2012-22196,0,0,090000648110ecf1
FDA-2012-N-0902-0002,FDA,FDA-2012-N-0902,Withdrawal of Approvals of New Animal Drug Applications: Chorionic Gonadotropin; Naloxone; Oxymorphone; Oxytocin,Notice,Letter,2012-09-10T04:00:00Z,2012,9,2012-09-10T04:00:00Z,,2012-10-17T20:10:16Z,2012-22195,0,0,090000648110eb54